|
Cambridge Major Laboratories, Inc.
Cambridge Major Laboratories, Inc. (www.c-mlabs.com) is a service-based chemistry outsourcing partner to the world’s leading pharmaceutical and biotechnology companies. The Company operates two facilities outside of Milwaukee, WI offering synthesis and scale up, analytical chemistry services and associated regulatory support for active pharmaceutical ingredients (“APIs”) across a broad range of structural classes of molecules. Cambridge Major’s core services are targeted at a diversified customer base of pharmaceutical companies including large multinationals, generic manufacturers, emerging biotechnology companies and specialty pharmaceutical concerns. The company is headquartered in Germantown, WI.
Arlington has made an investment in CML in partnership with the company’s existing management team. CML is led by its Chief Executive Officer, Michael Major, Ph.D., D.Sc., who, in conjunction with CML’s management team, has been responsible for the company’s growth since its founding in 1997. Michael Major is an industry leading expert in chemical synthesis and is currently the President of the Wisconsin Biotechnology and Medical Device Association. In addition, Dr. Major was recently named Entrepreneur of the Year in the category of Life Sciences by Ernst & Young.
(Press Release for Acquisition of ChemShop B.V.)
(Press Release for Investment in CML, Inc.)
|
